3 This effect on lowering triglycerides is extremely relevant as many people taking statins still have elevated triglycerides, and high triglycerides are an independent risk factor for cardiovascular disease
Cardiovascular, mortality, and kidney outcomes with Glp-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Given that several further dual agonists are coming closer to becoming licenced, such as mazdutide and survodutide, with many more in development [15], combining licenced dual agonists with developing mono-agonists may be a faster way to develop effective treatments achieving triple agonism
What inspires you to be a leader and spokesperson in the wellness movement
GLP-1 receptor agonists such as semaglutide and liraglutide are prescribed for diabetes and, under specific NICE criteria, weight management through specialist services